Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06774703 · ClinicalTrials.gov registry record
Nemaline Myopathy Clinical Research Network (NM-CTRN)
A clinical trial, sponsored by Stanford University.
- Not yet
- Registry status
- 50
- Enrollment target
NCT06774703: Clinical Trial study, sponsored by Stanford University.
NCT06774703 is a clinical trial that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06774703 has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
The goal of this study is to establish a research network to help define the natural disease history and clinical outcome measures for Nemaline Myopathy (NM).
Primary Outcome
The AIMS is a standardized tool used to assess a child's gross motor development in four positions: prone, supine, sitting, and standing. Percentile scores are given from 0-100, with higher percentiles representing higher motor function.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-01 |
| Est. Completion | 2029-12 |
What is known before NCT06774703 opens enrollment
NCT06774703 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT06774703 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06774703 about?
NCT06774703 is a clinical study titled "Nemaline Myopathy Clinical Research Network (NM-CTRN)". The goal of this study is to establish a research network to help define the natural disease history and clinical outcome measures for Nemaline Myopathy (NM).
What is the current status of trial NCT06774703?
This trial is currently not yet recruiting. The enrollment target is 50 participants. The study started on 2025-01. Estimated completion is 2029-12.
Who is sponsoring clinical trial NCT06774703?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia